Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif
The recent introduction of sTSH assays allows for a definite control of the inhibition of TSH secretion. Clinical examination and serum thyroid hormone measurements are necessary to obviate hyperthyroidism. Relapses may occur after decades of apparent complete remission. Follow-up should be pursued...
Saved in:
Published in | European journal of cancer & clinical oncology Vol. 24; no. 2; pp. 345 - 350 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.1988
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The recent introduction of sTSH assays allows for a definite control of the inhibition of TSH secretion. Clinical examination and serum thyroid hormone measurements are necessary to obviate hyperthyroidism.
Relapses may occur after decades of apparent complete remission. Follow-up should be pursued throughout the patient's lifetime. Two specific means allow the detection of relapses at a stage when X-rays are still normal: measurement of serum thyroglobulin and
131
I total body scan. Their combined use is recommended. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0277-5379 |
DOI: | 10.1016/0277-5379(88)90278-7 |